STO Medical Services organised the 'Cardio Metabolic Renal Conclave' conference at CROSSROADS Maldives on Friday, bringing together over 100 healthcare professionals to discuss chronic kidney disease, diabetes, and cardiac conditions. The event highlighted recent US FDA approval of an AstraZeneca-manufactured medication imported and distributed by STO for type 2 diabetes in children aged 10 and older.
One outlet so far Only Maldives Republic has reported this among the sources we monitor. A gap in what we monitor, not proof that others did not report it.
The conference, titled “Cardio Metabolic Renal Conclave,” held at CROSSROADS Maldives on Friday, highlighted the recent US FDA approval of a medication manufactured by AstraZeneca, imported, and distributed by STO.
Word for word from the report in Maldives Republic. Open the report
This medication is designed to improve glycemic control in children aged 10 years and older with type 2 diabetes, marking a crucial milestone for patients living with type 2 diabetes and extending the potential benefits to many more indivi…
This conference is a testament to STO’s commitment to improving healthcare outcomes and supporting medical professionals in their mission to provide the best possible care for their patients.
Nothing to compare yet. If another monitored source reports it, its headline appears beside this one.
State Trading Organization (STO) Medical Services recently brought together over 100 healthcare professionals to discuss critical issues related to chronic kidney disease, diabetes, and cardiac conditions.
Word for word from the report in Maldives Republic. Open the report
This medication is designed to improve glycemic control in children aged 10 years and older with type 2 diabetes, marking a crucial milestone for patients living with type 2 diabetes
Word for word from the report in Maldives Republic. Open the report